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ExerciseRegular physical exercise is well known to improve glucose and lipid metabolism in skeletal muscle.
However, the transcription factors regulating these adaptive changes are not well-characterised. Recently the
nuclear orphan receptor nur77 was shown to be induced by exercise and linked to regulation of metabolic
gene expression in skeletal muscle. In this study we investigated the regulation of nur77 in muscle by
different exercise-activated pathways. Nur77 expression was found to be responsive to adrenergic
stimulation and calcium inﬂux, but not to activation of the AMP dependent kinase. These results identify
the adrenergic-cyclic AMP-PKA pathway to be the most potent activator of nur77 expression in muscle and
therefore the likely cause of increased expression after exercise. We also identiﬁed nur77 expression to be
reduced in the muscle of obese/insulin resistant rats after high fat feeding. Furthermore exposure to fatty
acids, insulin or inﬂammation was not the cause of decreased nur77 expression in insulin resistant muscle.
This suggests a reduced responsiveness to adrenergic stimulation as the likely cause of diminished nur77
expression in muscle of high fat fed rats, which has been observed in obese/insulin resistant individuals. Our
results suggest adrenergic stimulation as the most important stimulus for nur77 expression and point to a
signiﬁcant role for this transcription factor in adaptive changes in muscle after exercise and in insulin
resistant states.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Skeletal muscle represents approximately 40% of body mass [1]
and accounts for 20–30% of total resting oxygen uptake [2,3] which
can increase to 90% during maximal physical activity [4]. Muscle is the
major site of glucose and lipid metabolism and dysregulation of either
of these metabolic pathways can contribute to the development of
metabolic diseases such as type 2 diabetes and cardiovascular
complications [5].
It is well established that regular physical exercise improves
glucose homeostasis and increases capacity for lipid oxidation in
skeletal muscle [6–9]. The beneﬁcial consequences of exercise
include acute effects, as well as chronic adaptations in skeletal
muscle which both impinge on insulin action. Whereas the acute
beneﬁts of exercise most likely revolve around utilising excess
energy stores, the chronic adaptations involve coordinated regula-
tion of speciﬁc gene expression [10]. Therefore exercise-induced
changes in transcriptional regulators in skeletal muscle are of great2010, Darlinghurst, Sydney,
eiter).
ll rights reserved.interest in helping to understand the long term beneﬁcial effects of
exercise.
Recently the nuclear orphan receptor Nr4a1, also known as nur77,
was reported to be induced after exercise bouts in human skeletal
muscle [11]. Interestingly, nur77 was also shown to be a transcrip-
tional regulator of genes linked to glucose as well as lipid metabolism
in muscle [12,13].
The Nr4a subfamily of nuclear receptors consists of three
members: Nr4a1 (nur77), Nr4a2 (nurr1) and Nr4a3 (nor1). All
three are immediate early genes reported to be induced in various
tissues by a variety of stimuli, including growth factors, cytokines,
hormones, fatty acids and physical stress [14–23]. Nr4a receptors are
involved in diverse tissue speciﬁc functions such as T-cell apoptosis
[24], inﬂammatory gene expression in macrophages [25], gluconeo-
genesis in the liver [26] and regulation of thermogenic capacity in
brown adipose tissue [18,27]. However the regulation of nur77
expression in skeletal muscle is not well understood.
In this study we have investigated the regulation of nur77
expression in muscle cells by exercise-activated signalling pathways
(adrenergic, calcium, and AMP dependent kinase (AMPK)).
Furthermore we have examined regulation of nur77 expression in
muscle of animals stimulated in vivo with a high fat diet, acute
Fig. 1. Nur77 mRNA in L6 myotubes in response to adrenergic stimulation. L6 myotubes
were stimulated with the beta-adrenergic pan-agonist isoproterenol (100 nM), the
beta-2-adrenergic agonist salbutamol (200 nM) and the adenylate cyclase activator
forskolin (10 μM) in a time course experiment for up to 24 h. The effect of medium
renewal at time zero on nur77 gene expression was also investigated. Nur77 transcript
is expressed as fold over basal expression. The results are mean values of three
independent experiments±standard error.
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AICAR.
2. Materials and methods
2.1. Reagents
Isoproterenol, palmitate, oleate, linoleate, LPS and insulin were
purchased from Sigma-Aldrich (Carlsbad, USA). AICAR was obtained
from Toronto Research Chemicals (Canada) and ionomycin, and
protein kinase A inhibitor 6-22 amide (PKAi) were from Calbiochem
(San Diego, USA).
2.2. Cell culture
L6 cells were maintained in alpha-MEM (Invitrogen, Carlsbad,
USA) supplemented with antibiotics and 10% FBS (Sigma-Aldrich,
Carlsbad, USA). At 70–80% conﬂuence mediumwas changed to alpha-
MEM supplemented with 2% FBS to initiate differentiation. At 7 days
post-differentiation cells were incubated with the respective sub-
stance for the indicated time. Fatty acids were ﬁrst coupled to BSA
(10%) and then further diluted in differentiationmedium resulting in a
ﬁnal BSA concentration of 2%.
2.3. Animal studies
Male Wistar rats weighing ∼250 g were purchased from the
animal resources center (Perth, Australia). The animals were kept in a
temperature-controlled room (22±1 °C) on a 12-h light/dark cycle
with free access to food and water. Rats were fed ad libitum for a
period of 3 weeks with a standard lab diet (8% calories from fat, 21%
calories from protein, and 71% calories from carbohydrate, 2.6 kcal/g;
Gordon's Specialty Stock Feeds, Yanderra, Australia) or with a high fat
diet (45% of calories from fat, 20% calories from protein, and 35%
calories from carbohydrates, 4.7 kcal/g, based on rodent diet no.
D12451; Research Diets, New Brunswick, NJ). All experiments were
carried out with the approval of the Garvan Institute/St. Vincent's
Hospital Animal Experimentation Ethics Committee, following guide-
lines issued by the National Health and Medical Research Council of
Australia. Lipid infusion, euglycemic hyperinsulinemic glucose clamps
and AICAR infusions were performed as described elsewhere [28–30].
2.4. RNA isolation and quantitative real-time PCR
After stimulation cells were harvested directly in TRI-reagent
(Sigma-Aldrich, Carlsbad, USA) and RNAwas isolated according to the
manufacturer's instructions. For the animal experiments tissue
samples were snap frozen in liquid nitrogen immediately after
dissection and 50 mg tissue was used for RNA extraction with TRI-
Reagent. RNA integrity was evaluated on agarose gels and concentra-
tion was spectrophotometrically determined using a Nanodrop
spectrophotometer. RNA was transcribed into cDNA with random
primers (New England Biolabs, Ipswich, USA) using the cDNA
synthesis kit from Qiagen (Mississauga, ON). Taqman probes
(Rn00577766_m1; Applied Biosystems) were employed to quantify
nur77 expression and normalized to 18 s-rRNA expression. PCR runs
were performed on an ABI 9600HT cycler using Taqman Gene
Expression Mastermix (Applied Biosystems, Foster City, USA) with
the standard PCR protocol as recommended by the manufacturer. A
standard curve, consisting of serial dilutions of pooled cDNA samples,
was measured with every PCR run to quantify nur77 transcript.
2.5. Statistical analysis
Values are given as means±standard error from at least three
independent experiments, which were performed in duplicate ortriplicate. Signiﬁcance was tested for by Student's t-test or two-way
ANOVA followed by Holm–Sidak post-hoc test and p-values lower
than 0.05 were considered to be signiﬁcant.
3. Results
3.1. Nur77 expression in response to increases in cAMP or intracellular
calcium levels and activation of AMPK
Exercise involves stimulation of the adrenergic-cyclic AMP-PKA
(protein kinase A), calcium signalling and AMPK pathways. Therefore
we applied agonists of these pathways to differentiated L6 myotubes
and examined the effect on nur77 gene expression. L6 myotubes were
treated with the beta-adrenergic pan-agonist isoproterenol, the beta-
2 agonist salbutamol and the activator of adenylyl cyclase forskolin for
up to 24 h and nur77 mRNA expression was measured. There was a
rapid but transient increase in nur77 expression following all
treatments with a peak of expression (∼200-fold) after 1 h returning
to basal levels after 4–6 h (Fig. 1). This conﬁrmed similar measure-
ments in C2C12 cells [12,13] and gave an indication of the time course
of nur77 expression in L6 myotubes. Because these agents were added
to the cells with a change of media, the effect of a media change on
nur77 expression was also examined. As previously observed in
adipocytes [31] changing the media of cultured muscle cells also
increased the expression of nur77 by several fold, however this
increase was much less than that brought about by addition of media
containing agonists of the adrenergic signalling pathway (Fig. 1). In all
subsequent experiments in muscle cells isoproterenol treatment
(100 nM) was included as a positive control and the effect of a
media change (from here on referred to as control) was used for
comparison to decide if any effects were speciﬁc for the added agonist.
To examine the effects of an increase in calcium ﬂux on nur77
expression, L6 myotubes were treated with the ionophore ionomy-
cin and nur77 transcript measured for 4 h after stimulation. Nur77
expression was signiﬁcantly increased following ionomycin treat-
ment at 1 h and was still above basal levels after 4 h of stimulation
(Fig. 2). Compared to the effect of isoproterenol however, only a
very mild induction of nur77 expression was observed. To exclude
activation of PKA by ionomycin [32] as a possible cause for
increased nur77 expression we used a peptide inhibitor of PKA
(PKAi) [33]. Inhibition of PKA had no effect on the induction of
nur77 by ionomycin (Fig. 2).
Next the effect of stimulation of AMP dependent kinase (AMPK)
(which is also activated during exercise), on the regulation of nur77
Fig. 2. Effect of AMPK activation and calcium inﬂux on nur77 expression in L6
myotubes. (A) Nur77 gene expression in L6 myotubes after AICAR (2 mM) or ionomycin
(1 μM) stimulation. STO-609 (10 μM) and PKA inhibitory peptide (PKAi;10 μM) were
used in combination with ionomycin. Isoproterenol (100 nM) was used as positive
control. Values are means of 5 independent experiments with the exception of the
inhibitors which were analysed in three independent experiments±standard error. (B)
Red and white quadriceps muscles were analysed for nur77 expression after 2 h of
AICAR or saline (control) infusion. Results are mean values of 6 (AICAR) or 4 (control)
animals±standard error. Statistical signiﬁcance (pb0.05) was tested with two-way
ANOVA and Holm–Sidak post-hoc test or Student's t-test.
Fig. 3. Effect of high fat diet feeding on nur77 expression in skeletal muscle of rats. After
3 weeks of high fat diet feeding nur77 expression was analysed in the red and white
quadriceps and the tibialis anterior muscle. Results are mean values of 6 animals
(tibialis n=3)±standard error. Statistical signiﬁcance pb0.05 was tested with
Student's t-test.
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AMPK activator AICAR for up to 4 h. We observed no changes in nur77
expression above those caused by replacing the media in response to
AMPK activation within 4 h (Fig. 2).
In order to compare our ﬁndings in L6 myotubes with the in vivo
situation we infused rats with AICAR. After 2 h of infusion, rats were
sacriﬁced and red and white quadriceps muscles were snap frozen.
Quantiﬁcation of nur77 transcript revealed no signiﬁcant changes in
gene expression within the red or white quadriceps muscle with
AICAR infusion (Fig. 2B).
3.2. Nur77 expression in skeletal muscle of high fat fed rats
Our previous experiments suggested that nur77 expression is
most responsive to beta-adrenergic stimulation and thereby to
activation of the cAMP-PKA pathway. It is reported that the
response to adrenergic stimulation is blunted in the muscle of
obese/insulin resistant individuals [34–37]. Therefore nur77 expres-
sion in skeletal muscle of rats after high fat feeding, a well-
characterised model of fat accumulation and insulin resistance was
investigated [38].
After 3 weeks of feeding a high fat diet rats were sacriﬁced and
tibialis anterior, red and white quadriceps muscles were dissected
and snap frozen. In high fat fed rats the expression of nur77 was
signiﬁcantly reduced compared to chow fed controls (∼50%). Thiseffect was of a similar extent in all three muscle groups analysed
(Fig. 3).
3.3. Effect of insulin, fatty acids and lipopolysaccharide (LPS) on nur77
expression in L6 myotubes
Insulin, fatty acids and inﬂammation (LPS) all have an impact on
metabolic regulation of skeletal muscle and are increased in obese/
insulin resistant individuals. These agents also induce nur77 expres-
sion in adipocytes [39], pancreatic beta-cells [23] and macrophages
[21], respectively. Therefore we treated L6 myotubes with these
substances to investigate any effect they may have on nur77
expression in muscle cells.
L6 myotubes were treated with 100 nM insulin and RNA was
isolated from samples taken after 30 min, 1 h and 4 h. Isoproterenol
treatment was included as positive control. Analysis revealed no
signiﬁcant induction of Nur77 mRNA in insulin-treated cells above the
levels of control cells (Fig. 4A).
Next the effect of the fatty acids oleate, palmitate and linoleate on
nur77 expression in L6 myotubes was investigated. Stimulation of up
to 16 h did not result in any changes in nur77 transcript above the
levels of control cells (Fig. 4B). Stimulation of muscle cells with the
pro-inﬂammatory agonist LPS over the same time course also failed to
raise nur77 expression above control cells although stimulation with
isoproterenol as a positive control rapidly increased nur77 expression
as expected (Fig. 4B).
Furthermore we investigated if fatty acids might prevent iso-
proterenol induced nur77 in L6 myotubes and therefore stimulated
cells with isoproterenol in combination with oleate, palmitate or
linoleate. None of the tested fatty acids did alter isoproterenol induced
nur77 expression (Fig. 4C).
3.4. Effect of insulin and lipid infusion on nur77 expression in skeletal
muscle of rats
Unstimulated L6 myotubes have very low levels of nur77 mRNA
compared to skeletal muscle, most likely because cultured myotubes
lack innervation. This makes it difﬁcult to use myotubes to test if
various stimuli reduce basal expression of nur77. Therefore we also
looked for possible effects of insulin and fatty acids on nur77
expression in vivo. We used rats infused with insulin or lipids to
investigate the effect on nur77 expression in skeletal muscle.
First we analysed tissue from chow or high fat fed rats that were
stimulated with insulin during a euglycemic hyperinsulinemic clamp.
After approximately 2 h of insulin infusion under euglycemic
conditions the rats were sacriﬁced and nur77 expression in the
tibialis anterior muscle was analysed. In line with our ﬁndings in L6
Fig. 4. Nur77 expression in L6 myotubes in response to insulin, fatty acids and LPS. L6 myotubes were stimulated for the indicated time and nur77 mRNAwas quantiﬁed by qRT-PCR.
(A) Stimulation with insulin (100 nM) for up to 4 h. (n=4; pb0.05 by two-way ANOVA and Holm–Sidak post-hoc test). (B) Stimulation with oleate (0.5 mM), palmitate (0.5 mM),
linoleate (0.5mM), LPS (1 μg/ml) or isoproterenol (100 nM)was performed for up to 16 h. (C) Effect of fatty acids on isoproterenol induced nur77 expression. Results aremean values
of three independent experiments. pb0.05 by two-ANOVA and Holm–Sidak post-hoc test.
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between insulin stimulated and control rats in the tibialis anterior
muscle (Fig. 5A).
Finally we infused rats with intralipid/heparin to acutely raise
fatty acids in the circulation and compared them with glycerol
infused animals. After 3 h of intralipid/heparin or glycerol infusion
the animals were sacriﬁced and the red quadriceps muscle was
dissected and snap frozen. Analysis of nur77 expression revealed no
signiﬁcant differences between intralipid/heparin and glycerol
infused rats (Fig. 5B).
4. Discussion
A wide variety of stimuli have been reported to increase nur77
expression in different non-muscle cell lines and tissues [14–23].
The only known stimulus to induce nur77 expression in muscle
cells is beta-adrenergic stimulation or any other treatment which
increases cAMP levels [12,13,40,41]. Physical exercise is the only
physiological condition reported to induce nur77 in skeletal muscle
[11].
Nur77 was recently reported to be involved in the regulation of
glucose and lipidmetabolism inmuscle [12,13]. Dysregulation of these
two metabolic pathways is a hallmark of the cluster of clinicalconditions referred to as the metabolic syndrome (insulin resistance,
type 2 diabetes, dyslipidemia, hypertension, obesity) and interestingly
all these conditions are improved by physical exercise [6–9]. In fact,
lifestyle intervention consisting of increased physical exercise and
moderate calorie intake is considered one of the most effective
treatments for the metabolic syndrome [8].
We examined three different signalling cascades activated by
exercise in skeletal muscle (adrenergic stimulation, calcium inﬂux and
AMPK activation). Beta-adrenergic stimulation or increases in cAMP
levels mediated by substances such as forskolin were found to be very
potent activators of nur77 expression in skeletal muscle cells. It is well
documented that the PKA target cAMP response element binding
protein (CREB) is critical for the induction of nur77 expression in
different tissues [40,42,43].
Interestingly we found nur77 expression in muscle also to be
responsive to increased intracellular calcium concentrations. Calcium
inﬂux is known to activate calmodulin dependent kinases (CamKs) as
well as classical PKCs (protein kinase C). Both can phosphorylate and
thereby activate CREB [44,45]. We excluded activation of PKA by
ionomycin treatment as the cause for increased nur77 expression as
PKA inhibition did not prevent ionomycin induced nur77 expression.
This points towards CamK or PKC as activators of nur77 expression in
muscle cells.
Fig. 5. Effect of insulin and lipid/heparin infusion on nur77 gene expression in rat
skeletal muscle. (A) After 2 h of insulin infusion during an euglycemic hyperinsulinemic
glucose clamp (insulin) nur77 expression in the tibialis anterior muscle was measured
in chow or high fat fed rats and compared with control animals (basal). Results are
mean values of four animals (6 for high fat)±standard error; (B) Nur77 expressionwas
analysed in the red quadriceps muscle of rats after 3 h of intralipid/heparin infusion or
glycerol infused control rats. Results are mean values of 4 (intralipid) and 3 (glycerol)
animals±standard error.
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ence nur77 expression in muscle is the AMPK pathway. AMPK has
been reported to directly phosphorylate and activate CREB in liver and
muscle cells [46]. Since CREB is the main transcription factor driving
nur77 expression we were surprised that AMPK activation had no
effect on nur77 expression. However, these in vitro results were
replicated in AICAR-infused rats, which showed no change in nur77
expression in skeletal muscle compared to saline infused rats.
Therefore it appears that AMPK activation is unlikely to be the
stimulus for increased nur77 expression in skeletal muscle during
exercise.
Overall our ﬁndings suggest that activation of PKA via increases
in cAMP is the most potent activator of nur77 expression in
skeletal muscle. The main stimulus activating PKA in skeletal
muscle in vivo is beta-adrenergic stimulation. The two sources of
catecholamines in muscle are noradrenaline released from nerve
endings and circulating adrenaline from the adrenal glands.
Bilateral adrenalectomy is known to reduce the levels of adrenaline
in skeletal muscle almost to zero [47]. Interestingly we have found
that nur77 gene expression is downregulated approximately 3-fold
in muscle of adrenalectomised rats as compared to sham operated
animals (D. Proctor, T. Kanzleiter and G. Cooney unpublished
observations). These ﬁndings support the notion that nur77
expression is mainly regulated by beta-adrenergic stimulation in
skeletal muscle.
There is a growing body of literature suggesting that although in
obese insulin resistant individuals the overall activity of the
sympathetic nerve system (SNS) is increased, there is a blunted
responsiveness to beta-adrenergic stimulation (presumably via a
decrease in beta-adrenoreceptors [36]) in adipose tissue and skeletal
muscle [34,35,48–50] (recently reviewed in [51]).Therefore to determine if nur77 expression may be altered in
association with insulin resistance we examined muscle from high fat
fed rats. Basal nur77 expressionwas signiﬁcantly reduced inmuscles of
high fat fed insulin resistant rats as compared to chow fed controls.
Given the fact that high fat feeding of rats results in SNS hyperactivity,
as evidenced by increased noradrenaline turnover and/or circulating
levels [37,52,53], it is tempting to hypothesise that basal nur77
expression is reduced in insulin resistance due to decreased respon-
siveness to beta-adrenergic stimulation. Indeeddenervation of skeletal
muscle is known to induce insulin resistance [54,55] and was recently
shown to diminish nur77 expression [13]. Furthermore in other rodent
models of obesity and insulin resistance (ob/ob and db/dbmice aswell
as Zucker rats) nur77 expression in muscle is reduced [39].
However, obesity and insulin resistance is accompanied by
elevated levels of insulin and fatty acids, as well as subclinical chronic
inﬂammation. Therefore we also examined a possible effect of these
factors on nur77 expression, particularly as in previous studies nur77
was reported to be induced by insulin [56], by the pro-inﬂammatory
agent LPS [21] and by fatty acids [23] in different cell types.
First we examined whether nur77 expression in skeletal muscle
could be regulated by insulin as reported by Wu et al. [56]. In contrast
to the results of Wu et al. we did not detect a change in nur77
expression in L6 myotubes stimulated with insulinwithin 4 h. In order
to exclude any effects insulin might have on nur77 expression after
prolonged exposure we extended our time course to 24 h but still
could not observe any changes in nur77 expression (data not shown).
To further conﬁrm our results we measured nur77 expression in
skeletal muscle of chow or high fat fed rats after a 2 h infusion with
insulin during a hyperinsulinemic euglycemic clamp. Consistent with
our in vitro results we could not ﬁnd changes in nur77 expression in
skeletal muscle in response to insulin stimulation.
Stimulation of L6 myotubes with the saturated fatty acid palmitate,
the monounsaturated fatty acid oleate, the polyunsaturated fatty acid
linoleate or the pro-inﬂammatoryagonist LPS didnot result in a change
in nur77 expression. The fatty acids also failed to affect isoproterenol
induced nur77 expression in myotubes. This observation in an in vitro
system was also conﬁrmed in vivo where no change in nur77
expression was seen in muscle from rats which had been infused for
3 h with intralipid/heparin to raise circulating fatty acids compared to
glycerol infused rats as controls. Collectively our ﬁndings suggest that
insulin, fatty acids and LPS have little direct effect on nur77 expression
in vitro and in vivo and this supports the hypothesis that a blunted
responsiveness to adrenergic stimulation may be the cause for
diminished nur77 expression in skeletal muscle of high fat fed rats.
In summary, our results show nur77 expression in muscle cells to
be markedly induced by stimuli activating the cAMP-PKA-CREB
pathway and to a lesser extent by increases in intracellular calcium
levels presumably via classical PKCs. Therefore we speculate that
increases in nur77 expression in response to exercise are mainly
mediated via activation of the adrenergic system. Furthermore we
observed that basal nur77 expression was signiﬁcantly reduced in
skeletal muscle of high fat fed, insulin resistant, rats. We excluded
several other potential factors (insulin, fatty acids and inﬂammation)
as being responsible for the changes in nur77 expression and
considering the ﬁndings from this study and others [13,39], we
hypothesise that the decrease in nur77 observed in insulin resistant
rats is probably due to decreased adrenergic responsiveness of the
muscle. Given the recent reports linking nur77 to the regulation of
glucose and lipid metabolism in skeletal muscle [12,13], further
research into the physiological function and dysregulation of nur77 in
muscle are warranted.
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